GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Around 31 million U.S. adults have taken a GLP-1 (half are still on it) and 12.5 million or more are doing it because they're obese or overweight. And while the medications offer some folks an ...

From wage hikes to school policy changes, dozens of new Illinois laws take effect July 1. Here’s a breakdown of the most notable ones.

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity ...

The NBA has officially set the 2025–26 salary cap at $154.647 million, locking in Scottie Barnes’ rookie-max extension at five years and $224.2 million.

For 1Q25, the Macquarie Small Cap Value Fund Institutional Class shares declined, although the Fund outperformed its benchmark. Click here to read the full commentary.

Market Cap of Euro Stablecoins Surges to Nearly $500M as EUR/USD Rivals Bitcoin's H1 Gains The combined market cap of EUR-pegged stablecoins has grown by 44%, with Circle's EURC leading the ...

Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinAer ® treatment of the posterior ...